The European Innovation Council awards €1.8 million to Vésale Bioscience’s PhageDiag project
Namur (Belgium), 13 January 2023 Vésale Bioscience is…
read moreNew solutions to fight antibiotic resistant infections
Stem from our advanced R&D on bacteriophages, our Mission is to develop robust modern solutions to fight antibiotic-resistant infections.
Antibiotic-resistant infections, also known as antimicrobial resistance (AMR), are a substantial public health issue. From 700 000/y deaths today, the AMR burden is expected to reach ten million/y deaths by 2050, more than cancer.
Our approach is to work on personalized, selective, and specific phage therapies against those multi-resistant bacterial infections.
They talk about us.
Don’t miss any important events or news about Vésale Bioscience.
Namur (Belgium), 13 January 2023 Vésale Bioscience is…
read moreBiosaxony, the Saxony’s Biotechnology, Medical Technology & Health…
read moreCMO Dr Vincent Grek joins Vésale Bioscience as…
read more